Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
Tibor Schuster,
Adnan Kastrati,
Shinsuke Yuasa,
Erion Xhepa,
Christian Kupatt,
Michael Joner,
Karl-Ludwig Laugwitz,
Heribert Schunkert,
Mark Lachmann,
Elena Rippen,
Moritz von Scheidt,
Teresa Trenkwalder,
Costanza Pellegrini,
Tobias Rheude,
Amelie Hesse,
Anja Stundl,
Gerhard Harmsen
Affiliations
Tibor Schuster
Department of Family Medicine, McGill University, Montreal, Quebec, Canada
Adnan Kastrati
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Shinsuke Yuasa
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
Erion Xhepa
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Christian Kupatt
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Michael Joner
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Karl-Ludwig Laugwitz
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Heribert Schunkert
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany
Mark Lachmann
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Elena Rippen
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Moritz von Scheidt
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Teresa Trenkwalder
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Costanza Pellegrini
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany
Tobias Rheude
Department of Cardiology, Deutsches Herzzentrum München, Technical University of Munich, Munich, Germany
Amelie Hesse
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Anja Stundl
First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Gerhard Harmsen
Department of Physics, University of Johannesburg, Auckland Park, South Africa
Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. This study aimed to analyse the recovery of extra-aortic valve cardiac damage in accordance with this novel stratification system following TAVR.Methods The proposed phenotyping approach was previously established employing data from 366 patients with severe AS from a bicentric registry. For this consecutive study, echocardiographic follow-up data, obtained on day 147±75.1 after TAVR, were available from 247 patients (67.5%).Results Correction of severe AS by TAVR significantly reduced the proportion of patients suffering from concurrent severe mitral regurgitation (from 9.29% to 3.64%, p value: 0.0015). Moreover, pulmonary artery pressures were ameliorated (estimated systolic pulmonary artery pressure: from 47.2±15.8 to 43.3±15.1 mm Hg, p value: 0.0079). However, right heart dysfunction as well as the proportion of patients with severe tricuspid regurgitation remained unchanged. Clusters with persistent right heart dysfunction ultimately displayed 2-year survival rates of 69.2% (95% CI 56.6% to 84.7%) and 74.6% (95% CI 65.9% to 84.4%), which were significantly lower compared with clusters with little or no persistent cardiopulmonary impairment (88.3% (95% CI 83.3% to 93.5%) and 85.5% (95% CI 77.1% to 94.8%)).Conclusions This phenotyping approach preprocedurally identifies patients with severe AS, who will not recover from extra-aortic valve cardiac damage following TAVR and whose survival is therefore significantly reduced. Importantly, not the degree of pulmonary hypertension at initial presentation, but the irreversibility of right heart dysfunction determines prognosis.